Albert Labs Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Public

  • Stock Symbol
  • ABRT

Stock Symbol

Albert Labs General Information

Description

Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of a clinical pathway.

Contact Information

Formerly Known As
Albert Labs International Corp, Albert Labs International Corp.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 6996, Merritt Avenue
  • Burnaby, British Columbia V5J 4R6
  • Canada
+1 (778)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
CNQ
Corporate Office
  • 6996, Merritt Avenue
  • Burnaby, British Columbia V5J 4R6
  • Canada
+1 (778)

Albert Labs Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Albert Labs Stock Performance

As of 15-Jul-2024, Albert Labs’s current market cap is $273K with 74.4M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$273K 74.4M 71.8K -$0.04

Albert Labs Financials Summary

As of 30-Sep-2023, Albert Labs has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,103
Revenue 0 0 0
EBITDA (1,697) (5,415) (1,496)
Net Income (1,709) (5,418) (1,498)
Total Assets 48 121 281
Total Debt 7
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Albert Labs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Albert Labs‘s full profile, request access.

Request a free trial

Albert Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing ment
Drug Discovery
Burnaby, Canada

New York, NY
 

Altrincham, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Albert Labs Competitors (2)

One of Albert Labs’s 2 competitors is Definium Therapeutics, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Definium Therapeutics Formerly VC-backed New York, NY
COMPASS Pathways Formerly VC-backed Altrincham, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Albert Labs Patents

Albert Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023023857-A1 Method and system for culturing filamentous organisms Inactive 24-Aug-2021

Albert Labs Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Albert Labs‘s full profile, request access.

Request a free trial

Albert Labs ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Albert Labs’s complete esg history, request access »

Albert Labs FAQs

  • When was Albert Labs founded?

    Albert Labs was founded in 2020.

  • Where is Albert Labs headquartered?

    Albert Labs is headquartered in Burnaby, Canada.

  • What industry is Albert Labs in?

    Albert Labs’s primary industry is Drug Discovery.

  • Is Albert Labs a private or public company?

    Albert Labs is a Public company.

  • What is Albert Labs’s stock symbol?

    The ticker symbol for Albert Labs is ABRT.

  • What is the current market cap of Albert Labs?

    The current market capitalization of Albert Labs is $273K.

  • Who are Albert Labs’s competitors?

    Definium Therapeutics and COMPASS Pathways are competitors of Albert Labs.

  • What is Albert Labs’s annual earnings per share (EPS)?

    Albert Labs’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process